Immunodeficiency viruses undergo fusion with llposomes containing anionic phospholipids . We have investigated the effect of liposomes composed of cardiolipin, phosphatidylserine or phosphatidylinositol, on the infectivity of three strains of HIV-1 in A3.01 and H9 cells, measured by p24 (gag) production in the medium. The infectiVity of HIV-1 in A3.01 or H9 cells was inhibited by the presence of cardiolipin Iiposomes during a 2h infection period, with ICso's of 23.0, 4.8, and 5.0 ILM phospholipid, respectively, for the different strains. Liposomes composed of phosphatidylserine or phosphatidylinositol were ineffective under similar conditions. However, prolonged pre-incubation of the virus with these llposomes also inhibited infectivity. Inhibition of virus binding to cells could not account for the inhibition of infectivity. We propose that the fusion products of HIV-1 and anionic Iiposomes are impaired in their ability to fuse with the plasma membrane.
Introduction
Human immunodeficiency virus type 1 (HIV-1) primarily infects human T-Iymphocytes, monocytes and macrophages, and other cell types that express the CD4 antigen . on the cell surface (Dalgleish et aI., 1984; Klatzmann et aI., 1984; Gartner et al., 1985; Ho et aI., 1986) . The CD4 protein also serves as the receptor for simian immunodeficiency virus (SIV mac ) (Kannagi et aI., 1985) . However, cells that do not express detectable amounts of CD4 can also be infected with HIV-1 (Clapham et sl., 1989; Harouse et al., 1989; Tateno et aI., 1989) . Furthermore, expression of the human CD4 molecule on the cell surface via transfection may not be sufficient for HIV or SIV infection (Maddon et aI.,1986; Clapham et al., 1991) .
We have reported previously that HIV-1 and SIV mac can fuse with phospholipid membranes (liposomes) lacking the CD4 molecule (Konopka et aI., 1990; Larsen et al., 1990 Larsen et al., , 1991 . HIV-1 fuses both with negatively charged cardiolipin (CL, 1,3-bisphosphatidyl-sn-glycerol) liposomes and with positively charged liposomes composed of N-[2,3-(dioleyloxy)propyl]-N,N,N-trimethyl ammonium chloride (DOTMA), but only very slowly with neutral Iiposomes of dioleoylphosphatidylcholine (DOPC) (Konopka et aI., 1990 (Konopka et aI., , 1991 . The fusion of HIV-1 with CL Iiposomes is stimulated by reduced pH and the presence of calcium . Interestingly, the fusion of cationic or anionic liposomess with HIV-1 affects differentially the infectivity of the virus. Pre-incubation of HIV-1 with DOTMAliposomes or the addition of such Iiposomes during exposure of cells to the virus, enhances the infectivity ofthe virus (Konopka et sl., 1990 (Konopka et sl., , 1991 . The enhancing effect of DOTMA liposomes on HIV-1 infectivity is CD4-dependent, and appears to involve both virus-liposome fusion and liposome binding to the cell surface (Konopka et aI., 1991) . In contrast, preliminary results indicated that pre-incubation of HIV-1 with CL liposomes causes dose-dependent inhibition of HIV-1 replication in CD4+ A3.01 cells, as measured by p24 (gag) antigen production (Konopka et al., 1990 . The mechanism(s) of the inhibitory effect of CL Iiposomes on HIV-1 infectivity is unclear. It is possible that both the ability to fuse with the virus as well as the negative charge of cardiolipin liposomes may contribute to the observed inhibition. It is known that various negatively charged but non-fusogenic compounds exert antiviral activity in vitro against a variety of viruses, including HIV-1 (Takemoto and Spicer, 1965; De Somer et aI., 1968; Saba et aI., 1988) . Here, we examined whether the presence of CL Iiposomes during infection affected the infectivity of HIV-1 in two CD4 + cell lines, and investigated the susceptibility of three different isolates to this treatment. We focused on whether CL Iiposomes affect the cell or the virus membrane. Since pretreatment of A3.01 cells with cationic DOTMA Iiposomes enhances HIV-1 infectivity (Konopka et aI., 1991) , Results   Table 1 . Effect of medium composition on the fusion rate of HIV-1 with CL Iiposomes. a Initial fusion rates were calculated from the slopes of fluorescence dequenching per unit time. Values are given as % Fmax min-1.lnitial rates of less than 5 were averaged over the first min (the rates of fusion in these cases did not change appreciably with time). The others were averaged over the first 0.2 min. Reaction medium conditions were set prior to injection of CL liposomes {18.8fLMl. Virus concentration was 0.75 fL9 mr'. obtained with HIV-1LAV, at 4 ng of viral p24 per 10 6 cells (IC so of -20 fLM and -14 fLM, with p24 determinations after 7 and 10 days p.i., respectively; data not shown). CL liposomes present during exposure of A3.01 cells to HIV-1LAv-BRUIP reduced the infectivity of the virus to a greater extent (IC so -4.8 fLM, with p24 determination after 7 days p.i.) than that of HIV-1LAV ( Fig. 1B) . Complete inhibition of p24 production was achieved at concentrations of 25 to 100 fLM. CL liposomes, at concentrations of 1-100fLM and under such treatment conditions (2 x 10 7 cells mr': RPM1/10% FBS; 2h at 37°C), were not cytotoxic, as determined by trypan blue exclusion (data not shown). The infectivity of purified HIV-1LAv-BRU, used for the fusion experiments, was inhibited by CL Iiposomes to a similar extent as that observed with propagated virus (data not shown), although the overall production of p24 in A3.01 cells infected with the purified virus, at 4ng of viral 
HIV-t fuses with cardiolipin liposomes
HIV-1 fuses rapidly with CL liposomes, as detected by the dequenching of R 18 due to dilution of the probe within the fusion product. Fusion was also observed with both freeze-fracture and negative-stain electron microscopy . Fusion of HIV-1 with CL liposomes was dependent on the composition of the medium (fable 1). At pH 7.5, fusion was faster in the presence of RPMI than in NaClfTES buffer alone. This may be due to the fact that RPMI contains 0.45 mM Ca 2 + , but the other constituents of the medium may also playa role. Addition of 10% FBS significantly reduced, but did not completely eliminate HIV-1 fusion with CL Iiposomes. Thus, it is expected that the extent of fusion would reach significant levels following a 2 h or 24 h pre-incubation of the virus with CL liposomes in the presence of 10% FBS, as described below.
HIV-t infectivity is inhibited by cardiolipin liposomes present during the initial infection of A3.0t or H9 cells
When A3.01 cells were infected in the presence of CL liposomes with HIV-1 LAv, at 1Ong of viral p24 per 10 6 cells, the production of p24 antigen in the culture supernatant was inhibited with an IC so of -23 fLM (Fig. 1A ). Over 90% inhibition was observed at a lipid concentration of 100 fLM (p24 = 0.64 ± 0.003 and 88.1 ± 15.1 ng rnr' compared to 9.9 ± 1.5 and 6390 ± 206.6ng ml" for untreated controls, after 7 and 10 days p.i., respectively). Similar results were NaCllTES NaCllTES {0.5mM Ca2+l RPMI 1640 b RPMI1640 we investigated if the interaction of CL Iiposomes with host cells affect HIV-1 infectivity. We determined whether the effect of CL liposomes could be explained by its effect on virus binding to cells. We also examined whether two other negatively charged but less fusogenic liposomes, phosphatidylserine (PS)and phosphatidylinositol (PI) , could inhibit the infectivity of HIV-1. .p24/1 0 6 cells, was approximately 10 times lower than those infected with propagated HIV-1LAV-BRUIP (3.8 ± 0.1 VS. 34.4 ± 5.0ng p24 mr', respectively, on 7 day p.i.).
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Similar reduction of the production of p24 (IC so~5 /-LM) was also observed when CL Iiposomes were present during infection of A3.01 and H9 cells with HIV-1HTLV-IIIB (Table 2 ). The IC so values were similar regardless of when p24 production was measured (7,10,14, or 17 days p.i.) ( Table 2 and data not shown). The effect of CL liposomes on HIV-1LAV infectivity of H9 cells was not tested. The differential sensitivities ofthe three isolates of HIV-1 to the inhibitory effect of CL liposomes were not due to their different infectivities measured as TCID so . For example HIV-1LAv-BRUIP and HIV-1HTLV-IIIB differed by about 100-fold in TCID so per 100 ng of viral p24 (4.6 x 10 s and 4.8 x 10 3 , respectively). However, CL liposomes inhibited the infectivity of the two strains to a similar extent ( Fig. 1B and Table 2 ).
Presence of phosphatidylserine or phosphatidylinositol Iiposomes during the initial infection of A3.01 cells does not inhibit HIV-1 infectivity
To determine whether the inhibitory effect of CL llposornes on HIV-1 infectivity was due to the negative charge of the lipid, we tested the antiviral activity of two other negatively charged, but less fusogenic, liposomes. The rate of fusion of HIV-1 with negatively charged Iiposomes at neutral pH depends on the lipid composition, and decreases in the sequence pure CL > phosphatidylinositol (PI)> phosphatldylserine (PS) (Larsen et sl., 1991; and unpublished results) . When compared to pure CL Iiposomes the initial rate of HIV-1 fusion with PI or PS Iiposomes was decreased by about 9-and 19-fold, respectively, in NaCl/TES buffer, pH 7.5, in the absence of Ca 2 + , and by about 1O-fold in the presence of 0.5 mMCa 2 + . Addition of serum to the NaCl/TES buffer reduced HIV-1 fusion with CL liposomes by 97% (Table 1) . Thus, it is expected that the interaction of PI or PS liposomes with HIV-1 in the presence of 10% FBS would be very slow. In contrast to CL lipsomes, the addition of PI or PS liposomes during infection, at concentrations between 10 and 100/-LM, did not affect p24 production in A3.01 cells (Fig.  2) . The presence of PI or PS Iiposomes, at concentrations of 5 and 50/-LM, also had no effect on HIV-1 infectivity in A3.01 cells when the serum concentration was reduced to 0.2% during infection (data not shown). To compare adequately the fusion of HIV-1 with different Iiposomes, and the ability of these liposomes to inhibit infectivity, we also examined the effect of liposomes on the infectivity of the purified virus preparation used in the fusion studies.
Pre-incubation of HIV-1 with cardiolipin, phosphatidylserine or phosphatidylinositolliposomes reduces virus infectivity
Since HIV-1 could fuse with PS or Plliposomes and since neither liposome type inhibited HIV-1 infectivity when present during infection, we investigated whether preincubation of the virus with these liposomes affected infectivity. HIV-1LAV-BRUIP was pre-incubated with CL, PS, or PI liposomes, for either 2 h or 24 h at 37°C and then incubated with A3.01 cells for 2h. The amount of HIV-1 p24 antigen released into culture supernatants (Table 3) indicates that pre-incubation of HIV-1 with CL, PS, or PI liposomes resulted in a dose-and time-dependent inhibition of virus replication. The inhibition of p24 production in the supernatant of HIV-1-infected cells correlated with the fusogenic activity of negatively charged Iiposomes in NaCl/TES buffer alone. Both PS and PI liposomes had some inhibitory effect at 5 /-LM. At a concentration of 50 /-LM, PS Iiposomes, which fuse significantly slower with HIV-1 than CL or Plliposomes , inhibited p24 production 3 days p.i. by 22% and 70%, after 2h and 24h pre-incubation, respectively. Pre-incubation of HIV-1 with 50/-LM Plliposomes for 2 h or 24 h reduced the infectivity of
Inhibition of infectivity by cardiolipin liposomes is not due only to decreased virus binding to cells
We investigated whether decreased infectivity in the presence of CL Iiposomes was due to inhibition of virus the virus by 46% and 100%, respectively. Under the same conditions, 5 and 50/-LM CL Iiposomes inhibited viral replication by 99% and 100%, respectively, after a 2h pre-incubation, and by 100% after a 24h pre-incubation. Similar results wre obtained after 7 days post-infection (Table 3) .
Pre-incubation of A3.01 cells with cardiolipoin Iiposomes does not affect HIV-1 infectivity
To determine whether the inhibitory effect of CL Iiposomes was due to binding to sites on the cell surface, A3.01 cells were pre-incubated with various concentrations of CL liposomes (10 to 100 /-LM lipid), both in the presence of 10% FBS and without serum. The cells were then washed and exposed to HIV-1 LAV at 4ng viral p24/10 6 cells, as described in Methods, and cultured for 7 days. Under such treatment conditions CL liposomes showed no cytotoxicity to the cells in the presence of serum (data not shown). However, in the absence of serum cytotoxicity of CL liposomes was observed with a CDso of -25/-LM. Pretreatment of A3.01 cells with CL Iiposomes in the presence of 10% FBS did not affect p24 production when compared to untreated cells. For example, when A3.01 cells were pre-treated with 50 or 100 /-LM CL liposomes, the values of p24 determined in the supernatant after 7 days were 2.75 ± 0.21 and 2.35 ± 0.28ng mr', respectively, while for cells treated with RPM) medium alone (control) this value was 2.78 ± 0.59 ng rnr' (the mean ± standard deviation.n = 4). a HIV-1LAV BRUIP was pre-incubated without or with CL, PI, or PS liposomes for 2 h or 24 h at 37°C. A3.01 cells were infected with pre-incubated HIV-1LAV-BRUIP (4ng of viral p24 per 10 6 cells). OJ .e. 20
and/or arginine residues on CD4 involved in gp120 binding (Schols et aI., 1989) . Sulphated polysaccharides (dextran sulphate, pentosan polysulphate, heparin) and modified, negatively charged, human serum albumins appear to inhibit HIV infection by interfering with virus attachment and fusion (Baba et al., 1988; Mitsuya et et., 1988; Jansen et al., 1991) . Recently, it was proposed that dextran sulphate interacts with positively charged amino acids concentrated in the V3 region of gp120 (Callahan et al., 1991) . It is possible that interactions with this region are also responsible for the observed inhibitory effect of CL Iiposomes. Negatively charged molecules can also affect cell surface CD4. Gangliosides, negatively charged glycolipids containing sialic acids, are known to down-modulate surface CD4 (Offner et al., 1987) and the CD4/Thy-1 fusion protein, which is anchored to the membrane by a glycosylphosphatidylinositol tail (Jasin et al., 1991) . Sulphation of gangliosides enhances their inhibitory effect 
Discussion
Our results indicate that CL liposomes are inhibitory to HIV-1 infection of two CD4+ T-cell lines, A3.01 and H9. Similar results were obtained with a human monocytic leukaemia cell line, THP-1 (unpublished observations). The inhibitory effect of CL liposomes on HIV-1 infectivity does not appear to be merely due to the negative charge of the lipid, since two other negatively charged liposomes composed of PI or PS affected HIV-1 infectivity only after prolonged pre-incubation with the virus. Although the initial rate of fusion between HIV-1 and CL Iiposomes was reduced after addition of serum to RPMI medium (fable 1), virus and Iiposomes can fuse with each other to a significant extent during a 2 h incubation. One reason for the lack of anti-HIV-1 activity of PI and PS liposomes present during the infection period may be their lower fusion activity compared to CL liposomes. Although all these lipids carry 1 net negative charge per 2 acyl chains, the molecular arrangements and nature of the charged groups are different. PS has carboxy, phosphate and amino groups connected to 2 acyl chains, while CL has two phosphate groups connected to 4 acyl chains via a glycerol backbone, and PI contains a phosphate moiety shielded by the inositol residue. Earlier reports have indicated that various negatively charged compounds exert antiviral activity against a variety of viruses in vitro (Takemoto and Spicer, 1965; De Somer et aI., 1968; Baba et aI., 1988) but the exact mechanism(s) of their inhibitory effect remains obscure. Sulphonated compounds such as suramin (bis-naphthalenetrisulphonic acid), suramin analogues, and Evans blue inhibit HIV replication (Balzarini et al., 1986a (Balzarini et al., , 1986b Mohan et al., 1991) . Aurin tricarboxylic acid is thought to inhibit HIV adsorption to host cells by binding to lysine binding to cells. Binding was measured at O°C since HIV-1 is not expected to fuse at this temperature (Sinangil et aI., 1988; Orloff et al., 1991) . A3.01 cells were exposed to the virus at O°C, in the absence or presence of CL Iiposomes. The Iiposomes and free virus were then removed by washing the cells. The presence of CL Iiposomes, at concentrations of 5-50 [LM, reduced binding of HIV-1 by 29% and 32%, respectively (Fig.3a ).This bound virus was allowed to infect the cells by raising the temperature to 3YOC and virus production in the supernatant was determined 3 days p.i. (Fig. 3B) . Similar results were obtained after 5 days p.i. (data not shown). At 50 [LM CL the amount of p24 was reduced to 3% of that produced by control cells treated identically except for the absence of liposomes. In a separate experiment 50 [LM CL reduced binding by 56% while inhibiting infectivity by 88% (12% of p24 production in controls). Thus, infectivity was inhibited to a greater extent than binding. compared to unsulphated analogues even in the presence of 10% FBS (Handa et aI., 1991) . Liposomes containing sulphated galactocerebroside (sulphatide) or cholesterol sulphate also inhibit syncytium formation induced by bovine immunodeficiency virus (BIV) infected cells (Watari et aI., 1990) . The inhibitory effect of sulphatide alone, not incorporated into liposomes, is low and the fusion of liposomes containing sulphated lipids with the membranes of BIV-infected and/or -uninfected cells has been suggested as an important step in the antiviral activity (Watari et aI., 1990) .
CL liposomes inhibited the original step of infection, HIV-1 binding to the cell surface, to a certain extent. However, this level of inhibition (43%) could not account for the extent of inhibition of the subsequent infection (97%). The ability of the fusion product to fuse with fresh CL Iiposomes is indeed diminished, as demonstrated by R 18 fluorescence dequenching experiments (C. E. Larsen et aI., personal communication). Future studies will examine whether CL liposomes inhibit the initial fusion step, by assaying virus-cell membrane lipid mixing and the intracellular delivery of p24, and monitoring the reverse transcription step by means of PCR analysis.
Our studies indicate that the antiviral effects of CL liposomes vary quantitatively among different strains of HIV-1 propagated in different cell lines. These findings were not unexpected, since strain specific antiviral effects of dextran sulphate (Busso and Resnick, 1990; Schols et al., 1992) and rsCD4 (Daar et al., 1990) have also been reported. Passage of HIV-1 isolates through various human cell lines can alter the cellular host range tropism (Cheng-Mayer et al., 1991; Peden et al., 1991) , because of differences in the cell-type-dependent glycosylation of the same viral envelope protein (Cheng-Mayer et al., 1991) . It has been also suggested that the genotypes of some viruses in vitro are not stable and that selection for growth causes the appearance of variants with increased growth potential and expanded host range in the absence of immune selection of the host (Peden et aI., 1991) . Therefore, it will be of interest to examine the effect of anionic Iiposomes on the infectivity of well characterized isolates that differ extensively with respect to sequence and biological properties.
Our observations with CL liposomes raise the possibility of using such liposomes for therapeutic purposes. The concentrations of liposomes necessary tor complete inhibition of infectivity are up to 1OO-fold lower than those injectable intravenously into experimental animals. Moreover, liposornes with long circulation times have been developed recently (Gabizon and Papahadjopoulos, 1988) . It will be of interest to examine whether similar Iiposomes containing relatively low mole fractions of CL will inhibit infectivity and retain their ability to circulate for long periods in serum. HIV infectivity may not only be inhibited by Iiposomes themselves but also by encapsulated antiviral drugs which can enter the virus interior via fusion. Additionally, the covalent coupling of rsCD4 to the Iiposomes may render the Iiposomes highly specific for binding to and fusion with HIV-1 or HIV-infected cells . These studies are in progress in our laboratory. 
Materials and Experimental procedures
Cell lines
The CD4+ human Iymphoblastoid cell line, A3.01, was obtained from T. Folks, and the H9 cell line was obtained from R. C. Gallo, through the AIDS Research and Reference Reagent Programme (Division of AIDS, NIAID, NIH, Bethesda, MD). H9/HTLV-IIIB cells were kindly provided by J. Mills (San Francisco General Hospital). The cells were maintained in RPMI 1640 medium (Irvine Scientific, Santa Ana, CAl supplemented with 10% (vlv) heat-inactivated fetal bovine serum (FBS) (Irvine Scientific), penicillin (50 units mr '),streptomycin (50 fL9 mr '),and L-glutamine (2mM)at 37"C.
The cells were split 1:6 and fresh medium was added every 3-4 days.
Fusion experiments
To determine the fusion of HIV-1 with llposornes, the virus (LAV-BRU, now designated as LAV-LAI [Wain-Hobson et al., 1991] [Pasteur Institute, Paris, France]) was propagated in human Iymphoblastoid leukaemia (CEM) cells, purified as described and stored at -70°C. This preparation was provided by M. Jennings (Department of Medical Pathology, UC Davis). Purified HIV-1LAV-BRU contained all viral antigens, including gp41 and gp120 (detected by Western blot), and was infectious as determined by its ability to induce syncytia formation and cell-free p24 antigen production in A3.01 cells. HIV-1LAV-BRU (100fL9) was labelled with octadecylrhodamine (R 18 ) at 3 mole% of the total viral lipid, by incubating the virus with an ethanolic solution of the fluorophore (final [ethanol] <1 %) for 1 h at room temperature (Hoekstra et al., 1984; Larsen et al., 1990) . It was necessary to use purified virus for these experiments to avoid labelling of other membranous material or serum components in cell culture supernatant. Free fluorophore was not present (an excess of added unlabelled virus did not result in redistribution of R 18 ; labelled virus chromatographed on Sephadex G-50 to eliminate any free R 18 gave similar results). R 18-labelled HIV-1 remained infectious as determined by the methods above. The dilution of R 18 into target membranes was measured by following the increase of rhodamine fluorescence, which results from the relief of self-quenching upon membrane fusion (Hoekstra et el., 1984) . Fluorescence measurements were performed with a Perkin-Elmer LS-5B fluorometer, as described earlier (Larsen et r el., 1990) . Maximal fluorescence (Fmax = 100%) was set by lysing the virus and Iiposome suspension with C 1 2Es (final concentration: 0.1-0.5% [wlv]), which completely disperses the fluorophore.
Virus stocks
The lJ>...V strain of HIV-1, designated as HIV-1LAV, was obtained from Dr T. M. Folks and propagated in A3.01 cells. The purified HIV-1 (labelled as HIV-1LAv-BRu) was also propagated in A3.01 cells, and the propagated virus was designated as HIV-1LAV-BRUlp. The supernatant of chronically infected H9/HTLV-IIIB cells was used as a source of the HIV-1 strain, HTLV-IIIB. The culture supernatants were harvested at times of peak p24 production, filtered through Millipore filters of 0.22 urn pore diameter, and stored in 1-ml aliquots at -80°C. The reverse transcriptase activity of the virus stock solutions was 8.8 x 10 5,2.5 X 10 6 , and 3.9 x 10 6 c.p.m. mr ' and the eusx-reactlve p24 protein yielded 1.0, 2.6, and 0.3f1g rnl" for HIV-1 LAv, HIV-1LAv-BRu/P and HIV-1HTLV-IIIB, respectively.
The tissue culture infectious dose, 50% endpoint (TCID 5 0 ) , was determined by inoculating replicate microtitre wells of A3.01 or H9 cells (2 x 10 4 cells well-1 ) in 96-well flat-bottom plates (Corning) with serial dilutions of cell-free supernatants (Johnson and Byington, 1990) . Each well was scored daily for evidence of virus-induced cytopathic effect (CPE) (the presence of syncytia, ballooning cytoplasm, etc.). The cells were split 1:2 twice weekly and fed with fresh medium, until peak infection was noted, usually after 9 or 10 days. The infectious titre per 100 ng p24 antigen was: HIV-1 LAv, 1.64 x 10 4 TCID 5 0 ; HIV-1LAv-BRUlP, 4.6 x 10 5 TCID 5 0 (both on A3.01 and H9 cells); and HIV71 HTLV-IIIB, 4.8 x 10 3TCID 5o , on H9 cells. Viral inocula were standardized by their p24 content, and cultures were infected at a concentration of p24 between 4 and 10ng p24 per 10 6 cells, as described in the Figure and Table  legends . Viral p24 antigen was determined in cell-free supernatant by the HIV-1 p24 antigen capture assay described previously (Konopka et et., 1990) .
Preparation of liposomes
Liposomes were prepared in 150 mMNaCI, 10 mM N-(Tris[hydroxymethyllmethyl)-2-aminoethane sulphonic acid (TES), pH 7.5, either by reverse phase evaporation (Szoka et a/., 1980) or by hydrating dried lipid (Bangham et a/., 1965) , and extruded three times under argon, through double polycarbonate membranes of 0.0811-m pore diameter in a Lipex Biomembranes (Vancouver, BC) high pressure extrusion apparatus, to achieve a uniform size distribution (Szoka et a/., 1980) . This procedure results in the production of predominantly unilamellar vesicles (DOzgOnel? et aI., 1983; Hope et a/., 1985) . The lipid concentration was determined by phosphate assay (Bartlett, 1959) .
HIV infection of cells
Cells (2 x 10 7 rnr') were exposed to HIV-1 for2hat37"C, washed three times to remove unbound virus, resuspended at 5 x 10 5 cells mr ' in RPMI-1640/1 0% FBS and cultured at 37°C in 12-well culture plates (4ml per well). Control cells were treated similarly but not exposed to the virus. Every 3 or 4 days, 3ml of the supernatant was removed and fresh medium was added. Following incubation for various time periods (e.g. 3, 7, 10 days), the Inhibition of HIV infectiVity by liposomes 185 number of viable cells was determined by Trypan Blue exclusion, and p24 antigen in the harvested samples of cell-free supernatant was measured by ELISA (Konopka et el., 1990) .
The effect of Iiposomes on HIV-1 infectivity was investigated using three different protocols: (1) the cell-free virus was pretreated with Iiposomes before addition to the cells, (2) Iiposomes were added to the culture medium during exposure of cells to virus, or (3) the cells were pre-treated with Iiposomes before addition of virus.
HIV-1LAv-BRUlP (O.4l1-g viral p24 mr')was pre-incubated with various concentrations of Iiposomes for 2h or 24h at 37"C and then diluted with a cell suspension to give 4ng of viral p2410-6 cells. Control virus was pre-incubated without Iiposomes.
A3.01 cells (2 x 10 7 cells mr ') were pre-incubated with various concentrations of CL liposomes for 1 h at 37°C, washed three times to remove unbound CL and then exposed to HIV-1LAV at 4 ng of viral p24 10-6 cells. After virus adsorption for 2 h at 37"C, the cells were washed three times, resuspended at 5 x 10 5 cells ml" and cultured in 12-well culture plates. Following incubation, cell viability was assessed visually both with and without the use of Trypan Blue, and p24 antigen was measured in duplicate in the supernatant.
Quantitation of HIV-1 binding to A3.01 cells
HIV-1LAV-BRu/P was added to A3.01 cells at 200ng of viral p24 per 2 x 10 6 cells in 0.2 rnl, at a multiplicity of infection (MOl) of 0.46 infectious virus/target cell. The virus-cell mixture, in the absence or presence of CL Iiposomes, was maintained at O°C for 60 min to allow binding without internalization. The cells were washed to remove unbound virus and divided into two portions, each containing 1 x 10 6 cells. The first portion of cells was lysed with 1% Triton X-100. The lysate, representing cell-bound and/or cell-internalized viral antigen, was centrifuged at 13000 x g for 10 min and p24 antigen was measured in the supernatant. The second portion was resuspended at 5 x 10 5 cells ml-1 and cultured in 24-well culture plates (2ml well-1 ) at 37"C, and on days 3 and 5 of culture, 1 ml of the supernatant was removed and fresh medium was added. The harvested samples of cell-free supernatant were tested for p24 antigen.
